The report entitled “Global Healthcare Contract Packaging Outsourcing (CPO) Market: Size, Trends & Forecasts (2017-2021)”, provides analysis of the global healthcare CPO market, with detailed analysis of market size and growth, segments and penetration.
Moreover, the report assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall healthcare CPO market has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Partners Group (PCI), UDG Healthcare Plc (Sharp) and FedEx (GENCO) are some of the key players operating in the global healthcare CPO market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Partners Group (PCI)
UDG Healhcare Plc (Sharp)
Contract packaging outsourcing (CPO) refers to the commissioning of packaging activities to third party vendors. In recent times, it has become common for manufacturing companies to outsource these non-core services in which they do not possess expertise/have knowledge to third party vendors. The pharmaceutical companies are also hiring CPO in order to focus on their core processes in a better manner.
The CPO market can be divided on the basis of services and verticals. On the basis of services, the market can be classified into primary, secondary and tertiary packaging. On the basis of verticals, the market can be divided into healthcare, food and beverage, home and fabric & beauty care. The healthcare CPO market can be further sub segmented into commercial and clinical segments.
The global healthcare CPO market is expected to increase at high growth rates during the forecast period (2017-2021). The global healthcare CPO market is supported by various growth drivers, such as strong growth in biologics market, better focus on core processes, exit of contract manufacturers and greater scrutiny by the FDA.
However, challenges associated with serialisation, less penetration of CPO in the healthcare industry, reluctance of pharmaceutical companies to outsource packaging activities and limited scope in the clinical segment are some of the challenges faced by the market. Increasing emphasis on serialisation and scope of consolidation in the future are some of the latest trends in the market.